Paclitaxel-Loaded Polymeric Micelles Modified with MCF-7 Cell-Specific Phage Protein: Enhanced Binding to Target Cancer Cells and Increased Cytotoxicity
- 2 June 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (4), 1007-1014
- https://doi.org/10.1021/mp1001125
Abstract
Polymeric micelles are used as pharmaceutical carriers to increase solubility and bioavailability of poorly water-soluble drugs. Different ligands are used to prepare targeted polymeric micelles. Earlier, we developed the method for use of specific landscape phage fusion coat proteins as targeted delivery ligands and demonstrated the efficiency of this approach with doxorubicin-loaded PEGylated liposomes. Here, we describe a MCF-7 cell-specific micellar formulation self-assembled from the mixture of the micelle-forming amphiphilic polyethylene glycol−phosphatidylethanolamine (PEG−PE) conjugate, MCF-7-specific landscape phage fusion coat protein, and the hydrophobic drug paclitaxel. These micelles demonstrated a very low cmc value and specific binding to target cells. Using an in vitro coculture model, FACS analysis, and fluorescence microscopy we showed that MCF-7 targeted phage-micelles preferentially bound to target cells compared to nontarget cells. As a result, targeted paclitaxel-loaded phage-micelles demonstrated a significantly higher cytotoxicity toward target MCF-7 cells than free drug or nontargeted micelle formulations, but failed to show such a differential toxicity toward nontarget C166 cells. Overall, cancer cell-specific phage proteins identified from phage display peptide libraries can serve as targeting ligands (“substitute antibody”) for polymeric micelle-based pharmaceutical preparations.Keywords
This publication has 25 references indexed in Scilit:
- Enhanced Binding and Killing of Target Tumor Cells by Drug-Loaded Liposomes Modified with Tumor-Specific Phage Fusion Coat ProteinNanomedicine, 2010
- Cytoplasmic Delivery of Liposomes into MCF-7 Breast Cancer Cells Mediated by Cell-Specific Phage Fusion Coat ProteinMolecular Pharmaceutics, 2010
- Tumor delivery of macromolecular drugs based on the EPR effectAdvanced Drug Delivery Reviews, 2010
- Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiencyNanomedicine: Nanotechnology, Biology and Medicine, 2010
- TAT Peptide and Its Conjugates: Proteolytic StabilityBioconjugate Chemistry, 2009
- Evolution of phage display: from bioactive peptides to bioselective nanomaterialsExpert Opinion on Drug Delivery, 2008
- Development of ligand-targeted liposomes for cancer therapyEmerging Therapeutic Targets, 2004
- Anticancer AntibodiesAmerican Journal of Clinical Pathology, 2003
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- Fatty acid acylated Fab‐fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brainFEBS Letters, 1991